Skip to content
drillr.ai
Sign up

ABVC

ABVC BIOPHARMA, INC.

NASDAQ · Healthcare · Biotechnology · US

$1.00
+1.51%
Ask drillr

  • Nov 2, 2026, 15:00 UTC

    ABVC BioPharma closed a private placement of original issue discount senior convertible promissory notes, generating approximately $3.39 million in gross proceeds before fees and expenses.

    Source:

  • Nov 2, 2026, 14:57 UTC

    ABVC BioPharma entered into a private placement of senior convertible promissory notes with an aggregate principal amount of $4,106,060 and a purchase price of $3,387,500.

  • Nov 2, 2026, 14:57 UTC

    ABVC BioPharma entered into a settlement agreement with Lind under which it will pay $625,000 and Lind Notes will be cancelled upon receipt of payment.

  • Aug 27, 2026, 00:00 UTC

    ABVC BioPharma, Inc. completed the spin-off of its subsidiary BioKey (Cayman), Inc. by distributing approximately 15% of BioKey's ordinary shares to ABVC stockholders as a pro rata dividend, effective August 21, 2026.